(Q45065669)

9 December 2017

Cooperation between fibroblast growth factor receptor-4 and ErbB2 in regulation of cyclin D1 translation (English)

1 reference

9 December 2017

1 reference

Magdalena Koziczak

1

1 reference

PubMed ID

15377668

9 December 2017

Nancy E Hynes

series ordinal

2

1 reference

PubMed ID

15377668

9 December 2017

language of work or name

English

0 references

publication date

17 September 2004

1 reference

Journal of Biological Chemistry

9 December 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

9 December 2017

279

1 reference

9 December 2017

50004-50011

1 reference

9 December 2017

48

1 reference

Untangling the ErbB signalling network

9 December 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

ErbB receptors: directing key signaling networks throughout life

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

The modular phosphorylation and activation of p70s6k.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Phosphatidylinositol 3'-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Tyrosine kinase inhibitors: from rational design to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Mechanism of action of the immunosuppressant rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Activation of p70/p85 S6 kinase by a pathway independent of p21ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Signal transduction pathways involved in phosphorylation and activation of p70S6K following exposure to UVA irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Oncogenic Ras and Akt Signaling Contribute to Glioblastoma Formation by Differential Recruitment of Existing mRNAs to Polysomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

Smart drugs: tyrosine kinase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

A strategy for the design of multiplex inhibitors for kinase-mediated signalling in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

p70s6k function is essential for G1 progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M404252200

21 January 2018

Identifiers

DOI

10.1074/JBC.M404252200

1 reference

9 December 2017

1 reference

PubMed ID

15377668